BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

578 related articles for article (PubMed ID: 33266042)

  • 1. The Role of APOBECs in Viral Replication.
    Xu WK; Byun H; Dudley JP
    Microorganisms; 2020 Nov; 8(12):. PubMed ID: 33266042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. APOBEC deaminases as cellular antiviral factors: a novel natural host defense mechanism.
    Franca R; Spadari S; Maga G
    Med Sci Monit; 2006 May; 12(5):RA92-8. PubMed ID: 16641889
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytidine deaminases as a weapon against retroviruses and a new target for antiviral therapy.
    Izumi T; Shirakawa K; Takaori-Kondo A
    Mini Rev Med Chem; 2008 Mar; 8(3):231-8. PubMed ID: 18336343
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Associations between activation-induced cytidine deaminase/apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like cytidine deaminase expression, hepatitis B virus (HBV) replication and HBV-associated liver disease (Review).
    He X; Li J; Wu J; Zhang M; Gao P
    Mol Med Rep; 2015 Nov; 12(5):6405-14. PubMed ID: 26398702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apolipoprotein B mRNA Editing Enzyme, Catalytic Polypeptide-Like Gene Expression, RNA Editing, and MicroRNAs Regulation.
    Cao W; Wu W
    Methods Mol Biol; 2018; 1699():75-81. PubMed ID: 29086369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiviral roles of APOBEC proteins against HIV-1 and suppression by Vif.
    Romani B; Engelbrecht S; Glashoff RH
    Arch Virol; 2009; 154(10):1579-88. PubMed ID: 19669862
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNAs regulate APOBEC gene expression.
    Cao W; Wu W
    Histol Histopathol; 2018 Feb; 33(2):117-120. PubMed ID: 28604942
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Further investigation of simian immunodeficiency virus Vif function in human cells.
    Gaddis NC; Sheehy AM; Ahmad KM; Swanson CM; Bishop KN; Beer BE; Marx PA; Gao F; Bibollet-Ruche F; Hahn BH; Malim MH
    J Virol; 2004 Nov; 78(21):12041-6. PubMed ID: 15479843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. APOBECs and Herpesviruses.
    Cheng AZ; Moraes SN; Shaban NM; Fanunza E; Bierle CJ; Southern PJ; Bresnahan WA; Rice SA; Harris RS
    Viruses; 2021 Feb; 13(3):. PubMed ID: 33671095
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intrinsic immunity against retrotransposons by APOBEC cytidine deaminases.
    Koito A; Ikeda T
    Front Microbiol; 2013; 4():28. PubMed ID: 23431045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A single amino acid substitution in human APOBEC3G antiretroviral enzyme confers resistance to HIV-1 virion infectivity factor-induced depletion.
    Xu H; Svarovskaia ES; Barr R; Zhang Y; Khan MA; Strebel K; Pathak VK
    Proc Natl Acad Sci U S A; 2004 Apr; 101(15):5652-7. PubMed ID: 15054139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanism of Enhanced HIV Restriction by Virion Coencapsidated Cytidine Deaminases APOBEC3F and APOBEC3G.
    Ara A; Love RP; Follack TB; Ahmed KA; Adolph MB; Chelico L
    J Virol; 2017 Feb; 91(3):. PubMed ID: 27881650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutagenesis of apobec-1, the catalytic subunit of the mammalian apolipoprotein B mRNA editing enzyme, reveals distinct domains that mediate cytosine nucleoside deaminase, RNA binding, and RNA editing activity.
    MacGinnitie AJ; Anant S; Davidson NO
    J Biol Chem; 1995 Jun; 270(24):14768-75. PubMed ID: 7782343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts.
    Mangeat B; Turelli P; Caron G; Friedli M; Perrin L; Trono D
    Nature; 2003 Jul; 424(6944):99-103. PubMed ID: 12808466
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A systems biology analysis of protein-protein interactions in the APOBEC family.
    Wang Y; Chen G; Yang Y; Hu Z; Chen X
    Life Sci; 2008 Oct; 83(15-16):521-30. PubMed ID: 18793652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A naturally occurring Vif mutant (I107T) attenuates anti-APOBEC3G activity and HIV-1 replication.
    Peng J; Ao Z; Matthews C; Wang X; Ramdahin S; Chen X; Li J; Chen L; He J; Ball B; Fowke K; Plummer F; Embree J; Yao X
    J Mol Biol; 2013 Aug; 425(16):2840-52. PubMed ID: 23707381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Natural resistance to HIV infection: The Vif-APOBEC interaction.
    Malim MH
    C R Biol; 2006 Nov; 329(11):871-5. PubMed ID: 17067930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ancient adaptive evolution of the primate antiviral DNA-editing enzyme APOBEC3G.
    Sawyer SL; Emerman M; Malik HS
    PLoS Biol; 2004 Sep; 2(9):E275. PubMed ID: 15269786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV-1 Vif can directly inhibit apolipoprotein B mRNA-editing enzyme catalytic polypeptide-like 3G-mediated cytidine deamination by using a single amino acid interaction and without protein degradation.
    Santa-Marta M; da Silva FA; Fonseca AM; Goncalves J
    J Biol Chem; 2005 Mar; 280(10):8765-75. PubMed ID: 15611076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term passage of Vif-null HIV-1 in CD4
    Miyagi E; Kao S; Fumitaka M; Buckler-White A; Plishka R; Strebel K
    Virology; 2017 Apr; 504():1-11. PubMed ID: 28131088
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.